Azulblue / Shutterstock.com

2 October 2025NewsAmericasSarah Speight

How impactful is the new USPTO director’s S101 decision?

As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, experts broadly welcome the decision—but encourage some caution, finds Sarah Speight.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

More features

Why AI is changing the patent rules faster than anyone can keep up

Is AI emerging as the ‘fourth party’ solving billion-dollar disputes?

The hidden code in life sciences deals

LSPN panel unpacks critical IP risks in deal-making

A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order

Less is more: patent lawyers flip the script after Amgen

‘Doing more with less’: In-house counsel on budgets and strategy

End of the ‘Death Squad’? Squires puts PTAB on trial